Navigation Links
FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
Date:6/23/2008

lexander, M.D., M.P.H., global head of research and development, Daiichi Sankyo Company, Limited.

About Trilogy ACS

The study, TRILOGY ACS (TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes), will include approximately 10,000 patients at more than 800 hospitals in 35 countries.

Daiichi Sankyo and Lilly are conducting the study in conjunction with the Duke Clinical Research Institute (DCRI), the world's largest academic clinical research organization and a part of Duke University Medical Center.

The study is a multi-center, double-blind, randomized, controlled trial to evaluate the safety and efficacy of prasugrel against clopidogrel in reducing the risk of cardiovascular death, heart attack or stroke in ACS patients who are to be medically managed without a planned artery-opening procedure.

Acute coronary syndromes, which comprises heart attacks and unstable angina (chest pain), affects more than 1.4 million people in the United States annually.(1) Despite currently available treatments, 320,000 people experience recurrent heart attacks each year.(2)

About prasugrel

Daiichi Sankyo Company, Limited (TSE: 4568), and Eli Lilly and Company (NYSE: LLY) are co-developing prasugrel, an investigational oral antiplatelet agent discovered by Daiichi Sankyo and its Japanese research partner, Ube Industries, Ltd., as a potential treatment, initially for patients with acute coronary syndromes who are managed with PCI. Prasugrel works by inhibiting platelet activation and subsequent aggregation by blocking the P2Y12 adenosine diphosphate (ADP) receptor on the platelet surface. Antiplatelet agents prevent platelets from clumping or sticking together, which c
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
2. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
3. FDA Extends Review of Genasense(R) NDA Appeal in Chronic Lymphocytic Leukemia
4. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
5. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
6. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
7. GSK Update on FDA Review of Promacta(R) (Eltrombopag)
8. ASPIRE Independent Review Board Announces 10 Ways to Protect Participants Rights in Clinical Drug Trials and Optimize Results From Research
9. CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting
10. Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures
11. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Pomerantz LLP has ... or the "Company") (NASDAQ: EDAP ) and ... United States District Court, Southern District of ... on behalf of a class consisting of all persons ... 2013 and July 30, 2014, inclusive (the "Class Period"). This ...
(Date:8/29/2014)... JORDAN, Utah , Aug. 29, 2014  BC ... Solutions, has acquired Polaris Medical Imaging, a leader in ... scanners. This strategic acquisition allows BC Technical to continue ... capabilities, specifically within MR and CT modalities. ... cost service," said Mark Alvarez , president and ...
(Date:8/29/2014)... your doctor know what you,re smoking?  Chances are, probably not.  ... over 112,000 currently registered patients under Colorado,s ... 20,300+ active physicians listed with the Colorado Dept of Regulatory ... a poll in February 2014 showed 51% of ... "With marijuana legalization underway, every doctor needs a ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3BC Technical Acquires Polaris Medical Imaging 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... May 5 Reportlinker.com announces that a new market research report is available in its catalogue: , ... Market , , , ... This Kalorama Information report - The World Anesthesia Drug Market - focuses on three primary segments of ... General Anesthesia , , , ...
... ,, SHENZHEN, China , ... Inc.,(Nasdaq: WWIN ; "Winner Medical" or the "Company"), ... PurCotton(R) materials,for the medical and consumer products industries, today ... quarter of fiscal year 2010 on, Tuesday, May 11 ...
Cached Medicine Technology:Reportlinker Adds The World Anesthesia Drug Market 2Reportlinker Adds The World Anesthesia Drug Market 3Reportlinker Adds The World Anesthesia Drug Market 4Reportlinker Adds The World Anesthesia Drug Market 5Reportlinker Adds The World Anesthesia Drug Market 6Reportlinker Adds The World Anesthesia Drug Market 7Reportlinker Adds The World Anesthesia Drug Market 8Reportlinker Adds The World Anesthesia Drug Market 9Reportlinker Adds The World Anesthesia Drug Market 10Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT 2Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT 3Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT 4
(Date:8/30/2014)... 2014 The SI Joint Evaluation and ... six muscle energy techniques. Michael P. Reiman PT, DPT, ... examination techniques for the SI Joint. This ... live course presentation with North American Seminars. ... Applying a differential diagnosis approach to a thorough examination ...
(Date:8/30/2014)... The KSF (Kung Fu Sanshou Federation) presents ... November 8th, 2014 at the Mobile Civic Center in ... many notorious and notable fighters for some top international ... , Among these KSF along with the Shaolin ... with the virtues of true indomitable Shaolin spirit, among ...
(Date:8/30/2014)... Spain Saturday 30 August 2014: The first ... patients with acute coronary syndromes (ACS) are published ... position paper was written jointly by the European ... Association (ACCA) and the European Association of Percutaneous ... , Professor Bulent Gorenek (Turkey), chairperson of the ...
(Date:8/30/2014)... 2014: The first recommendations on the use of ... published today in new ESC Guidelines. The guidelines ... V. Konstantinides (Germany/Greece) and Professor Adam Torbicki (Poland). ... and management of acute pulmonary embolism" are published ... on the ESC Website. , Venous thromboembolism (VTE) ...
(Date:8/29/2014)... August 29, 2014 Daily Gossip writes in ... program on the market nowadays. This method promises to teach ... the use of some effective alternative sources for the production ... energy sources are wind and solar power. , The ... easily accessible in an eBook. So, this is an online ...
Breaking Medicine News(10 mins):Health News:North American Seminars Online PT Continuing Education Course, Examination and Treatment of the SI Joint, Receives Continuing Education Approval in NJ, CA, IL, PA, & TX 2Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 2Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 3Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 4Health News:First multidisciplinary recommendations on management of arrhythmias in ACS patients 2Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:Home Made Energy Review Exposes Simple Method to Access Alternative Energy Sources 2
... reneged on its pledge to provide more flexible working in ... Journal. , Nearly 70% of medical students are women, and ... But despite its pledges in 2000, made in the governments ... the policy commitment made by the pay negotiating body NHS ...
... on why some people suffer from recurrent episodes of ... by a drop in blood pressure, fainting episodes, difficulty ... these individuals, researchers have found mast cells (a type ... a mutated cell surface receptor that disturbs normal processes ...
... New research explains why some ovarian cancer patients ... post-operative treatment. The findings show that the difference between ... the different biological properties of the tumors. Understanding ovarian ... exploration of specific tumor-targeted therapy, such as DNA profiling, ...
... Protection Awareness, NORTH CHICAGO, Ill., Nov. 9 ... ABT ) has donated a "Cool Globes",sculpture from ... the Lake,County Forest Preserves (LCFP) as a permanent display ... The "Cool Globes" program, which Abbott sponsored, featured ...
... 9 NutraCea (OTC Bulletin Board:,NTRZ), a health ... rice bran,(SRB), announced today that it will release ... after the market closes. Management will host ... PM EST,to review NutraCea,s 2007 third quarter financial ...
... 9 The Menninger Clinic, the,international specialty psychiatric ... Mental Health Epicenter -- that include The,Clinic,s new ... research,treatment, training and advocacy., Menninger will be ... Center on South Main Street, near South Post ...
Cached Medicine News:Health News:UK government has reneged on pledge for flexible working in NHS 2Health News:Abnormal immune cells may cause unprovoked anaphylaxis 2Health News:Abnormal immune cells may cause unprovoked anaphylaxis 3Health News:Abbott Donates 'Cool Globe' to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center 2Health News:Abbott Donates 'Cool Globe' to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center 3Health News:NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14 2Health News:The Menninger Clinic Unveils Plans for Mental Health Epicenter; Exceeds Halfway Point in $125 Million Capital Campaign 2Health News:The Menninger Clinic Unveils Plans for Mental Health Epicenter; Exceeds Halfway Point in $125 Million Capital Campaign 3
... a rapid, real-time thermal cycler used for ... automating much of the testing process, and ... is the fastest, easiest to use, and ... The SmartCycler delivers highly accurate and consistent ...
... is a rapid, real-time thermal cycler used ... By automating much of the testing process, ... it is the fastest, easiest to use, ... market. The SmartCycler delivers highly accurate and ...
... The SmartCycler System is a rapid, ... from prepared biological samples. By automating much ... reaction site individually programmable, it is the ... system now on the market. The SmartCycler ...
... is a rapid, real-time thermal cycler used ... By automating much of the testing process, ... it is the fastest, easiest to use, ... market. The SmartCycler delivers highly accurate and ...
Medicine Products: